Wall Street Journal: 3rd UPDATE: Shire To Buy Germany's Jerini, Boosting Portfolio
This event is older than two months and is no longer active. Some links older than two months could be broken. You can report a new related report by clicking the button below.
Thursday said it's acquiring German biotech company Jerini AG (JI4.XE) for EUR328 million, in a move that will boost its portfolio of drugs for rare genetic diseases. The acquisition will bring in Firazyr, an experimental drug that treats acute attacks of hereditary angioedema, a genetic disease...
- Share:
-
-
-
-
-
-
Site Links
Contributions
- Sign up, and add your voice by contributing to allvoices
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
